ADVFN Logo

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

AGIO Agios Pharmaceuticals Inc

29,24
0,12 (0,41%)
29 Mar 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 434 786
Prix Achat 28,89
Prix Vente 29,60
Actualités -
Maximum Haut 29,415

Bas
19,795

Sur 52 semaines

Haut
35,48

Minimum Bas 28,815
Nom Action Symbole Action Marché Type
Agios Pharmaceuticals Inc AGIO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,12 0,41% 29,24 01:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
29,19 28,815 29,415 29,24 29,12
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
6 834 434 786 US$ 29,16 US$ 12 677 558 - 19,795 - 35,48
Dernière Transaction Type Quantités échangées Prix transaction Devise
21:05:03 1 US$ 29,02 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
1,64B 56,19M - 26,82M -352,09M -6,27 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Agios Pharmaceuticals

Date Heure Source Titre
08/3/202400:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/3/202413:00GlobeNewswire Inc.Agios to Present at the Leerink Partners Global Biopharma..
01/3/202422:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
01/3/202422:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
01/3/202422:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
01/3/202422:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
29/2/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..

Forum Action Agios Pharmaceuticals

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Agios Pharmaceuticals Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine30,2731,4828,5729,58545 386-1,03-3,40%
1 mois34,2534,3728,5730,69688 675-5,01-14,63%
3 mois24,1435,4820,9627,09832 2675,1021,13%
6 mois24,4335,4819,79524,97720 9524,8119,69%
1 an22,2135,4819,79525,18566 4117,0331,65%
3 ans49,5762,15516,7532,05599 976-20,33-41,01%
5 ans64,0769,6416,7537,25637 922-34,83-54,36%

Dernières Valeurs Consultées

Delayed Upgrade Clock